IDH2 and central nervous system cancer: has explored the APT-CEST manifestations of IDH mutant glioma and found that APTw imaging hyperintensity could be a potential marker of active malignant glioma and is able to distinguish between regions of heterogeneous abnormality on anatomical brain MRI with 85.1% sensitivity and 94.1% specificity (7).